Insight
Structuring Cross-Border China Biotech “NewCo” Transactions
by Stephen Thau and Jeff Zhang
7 minute read | June.18.2025

by Stephen Thau and Jeff Zhang
7 minute read | June.18.2025
by SeoJung Park, Peter Elias and Eric Wall
2 minute read | June.17.2025
by Dr. Sven Greulich LL.M. (Cantuar), EMBA
4 minute read | June.17.2025
by Nathaniel Reisenburg, Joseph Perkins and Ignacio Sandoval
1 minute read | June.17.2025
by Irena Royzman Ph.D. and Saurabh Gupta
2 minute read | June.16.2025
Irena Royzman and Saurabh Gupta review the proposed guidance and make the case that it should be withdrawn.
by Julia Apostle and Rami Kawkabani
5 minute read | June.16.2025
by Albert Vanderlaan and Alice Hsu
3 minute read | June.16.2025
Continued volatility in the equity capital markets has revived what was thought to be a zombie after 2022 – the SPAC.
by Mike Delikat, Hayden Goudy, Tierra D. Piens and Meghan Conway
9 minute read | June.13.2025
by Dr. Lars Mesenbrink and Dr. Benedikt Kamann
3 minute read | June.13.2025
by Edward Dyson, Ed Lukins, Rebecca Servian and Abigail Parkin
1 minute read | June.13.2025
by Dr. André Zimmermann LL.M., Marianna Urban, Jonas Banse and Asalia Melanie Scheibner LL.M. (UCLA)
3 minute read | June.11.2025
by Marc R. Shapiro, Matthew D. LaBrie and Ian Hawkes
2 minute read | June.10.2025